407 related articles for article (PubMed ID: 25065875)
21. [Malignancy associated with hypercalcemia].
Eto S
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):371-6. PubMed ID: 8690997
[No Abstract] [Full Text] [Related]
22. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
23. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
24. Malignant hypercalcemia.
Basso U; Maruzzo M; Roma A; Camozzi V; Luisetto G; Lumachi F
Curr Med Chem; 2011; 18(23):3462-7. PubMed ID: 21756237
[TBL] [Abstract][Full Text] [Related]
25. A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
Kampfenkel T; Baraniskin A; Teschendorf C; Schmiegel W; Massenkeil G
Acta Haematol; 2010; 124(1):57-60. PubMed ID: 20616540
[TBL] [Abstract][Full Text] [Related]
26. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
Insogna KL
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
[TBL] [Abstract][Full Text] [Related]
27. [Hypercalcemia, symptoms, differential diagnostics and treatment, or importance of calcium investigation].
Adam Z; Starý K; Kubinyi J; Zajíčková K; Řehák Z; Koukalová R; Tomíška M; Doubková M; Prášek J; Pourová E; Čermáková Z; Pour L; Krejčí M; Sandecká V; Ševčíková E; Ševčíková S; Král Z; Čermák A
Vnitr Lek; 2016; 62(5):370-83. PubMed ID: 27319230
[TBL] [Abstract][Full Text] [Related]
28. [Penile carcinoma with humoral hypercalcemia of malignancy (HHM): a case report].
Sekita N; Furuya Y; Ueda T; Okano T; Ito H; Matsuzaki O
Hinyokika Kiyo; 1999 Jul; 45(7):497-9. PubMed ID: 10466069
[TBL] [Abstract][Full Text] [Related]
29. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
30. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin.
Dawson C; Todd AM; Walton A
J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187
[No Abstract] [Full Text] [Related]
31. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
32. Medical treatment of malignancy-associated hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Curr Med Chem; 2008; 15(4):415-21. PubMed ID: 18288996
[TBL] [Abstract][Full Text] [Related]
33. [Clinical aspects of calcium metabolism disorders of the bone. III. Current topics. 2. Hypercalcemia associated with malignant tumor: progress in the treatment].
Sato K
Nihon Naika Gakkai Zasshi; 1993 Dec; 82(12):2023-7. PubMed ID: 8294802
[No Abstract] [Full Text] [Related]
34. The hypercalcemia of malignancy: pathogenesis and management.
Mundy GR; Martin TJ
Metabolism; 1982 Dec; 31(12):1247-77. PubMed ID: 6755168
[TBL] [Abstract][Full Text] [Related]
35. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
Cisneros G; Lara LF; Crock R; Whittier FC
South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
[TBL] [Abstract][Full Text] [Related]
36. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
37. Malignant hypercalcemia in vulvar cancer.
Bilenchi R; Poggiali S; Pisani C; Santopietro R; Miracco C; Vatti R; Lucani B; Andreassi A; Gonnelli S
Minerva Ginecol; 2005 Oct; 57(5):569-74. PubMed ID: 16205603
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hypercalcemia of malignancy with bisphosphonates.
Berenson JR
Semin Oncol; 2002 Dec; 29(6 Suppl 21):12-8. PubMed ID: 12584690
[TBL] [Abstract][Full Text] [Related]
39. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
Brown GM; Morris CA; Mitnick MA; Insogna KL
J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
[TBL] [Abstract][Full Text] [Related]
40. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
